All Stories

  1. Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients
  2. Risk Prediction Models for Hypertensive Disorders of Pregnancy: Role of 12-Lead Electrocardiography
  3. Disconnect between basic science and clinical trials of infarct size reduction
  4. Unresolved issues in the management of chronic stable angina
  5. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention
  6. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure
  7. Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart
  8. Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricular ej...
  9. Functional and Morphological Changes in Endocrine Pancreas following Cola Drink Consumption in Rats
  10. Quadricuspid aortic valve: A case report and review of the literature
  11. Inverse expression of estrogen receptor alpha and apolipoprotein B in coronary intimal hyperplasia of surgically repaired congenital heart disease: A pre-atherosclerotic condition?
  12. Predictors of contemporary coronary artery bypass grafting outcomes
  13. CMR Assessment of Microvascular Obstruction in STEMI
  14. Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk
  15. Quantitative Assessment of Myocardial Blood Flow—Clinical and Research Applications
  16. Cardio–reno–hepatic interactions in acute heart failure: The role of γ-glutamyl transferase
  17. COST EFFECTIVENESS OF ZOFENOPRIL IN THE TREATMENT OF PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AFTER ACUTE MYOCARDIAL INFARCTION: A POST-HOC ANALYSIS OF THE SMILE-4 STUDY
  18. Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)
  19. The Impact of Strenuous Group Physical Activity on Mood States, Personal Views, Body Composition, and Markers of Myocardial Damage in Overweight/Obese Adults: The “Step-by-Step Italy’s Coast to Coast” Trek
  20. Impact of Obesity and Bariatric Surgery on Metabolism and Coronary Circulatory Function
  21. The ‘Echo Heart Failure Score’: an echocardiographic risk prediction score of mortality in systolic heart failure
  22. Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4
  23. Transforming Growth Factor β1 and Coronary Intimal Hyperplasia in Pediatric Patients With Congenital Heart Disease
  24. Causes of Death in Patients ≥75 Years of Age With Non–ST-Segment Elevation Acute Coronary Syndrome
  25. Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction
  26. Therapy Against Reperfusion-induced Microvascular Injury
  27. Endomyocardial Biopsy: A Clinical Research Tool and a Useful Diagnostic Method
  28. Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated With Coronary Artery Bypass Grafting
  29. Influence of midwall fibrosis on diastolic dysfunction in non-ischemic cardiomyopathy
  30. Angina pectoris in women: Focus on microvascular disease
  31. Microvascular Angina in Different Clinical Conditions: Diabetes and the Metabolic Syndrome
  32. Methods to investigate coronary microvascular function in clinical practice
  33. At-risk but viable myocardium in a large animal model of non ST-segment elevation acute coronary syndrome: cardiovascular magnetic resonance with ex vivo validation
  34. Coronary Vasomotor Control in Obesity and Morbid Obesity
  35. Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis
  36. Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated With Coronary Artery Bypass Grafting
  37. Assessment of flow-mediated dilation reproducibility
  38. Comparison Between Zofenopril and Ramipril in Combination With Acetylsalicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a Randomized, Double-Blind, Parallel-Group, Multicenter, European Stud
  39. Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight
  40. HPLC analysis of tetrahydrobiopterin and its pteridine derivatives using sequential electrochemical and fluorimetric detection: Application to tetrahydrobiopterin autoxidation and chemical oxidation
  41. Blood pressure lowering in diabetic patients
  42. Left Radial versus Right Radial Approach for Coronary Artery Catheterization: A Prospective Comparison
  43. Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
  44. National Society Cardiovascular Journals of Europe: Almanac 2011
  45. Improvement of Myocardial Performance (Tei) Index Closely Reflects Intrinsic Improvement of Cardiac Function: Assessment in Revascularized Hibernating Myocardium
  46. Presence of Extensive LV Remodeling Limits the Benefits of CRT in Patients With Intraventricular Dyssynchrony
  47. Assessment of Coronary Atherosclerosis Progression and Regression at Bifurcations Using Combined IVUS and OCT
  48. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients
  49. Ischemia with normal coronary arteries: a puzzle and an opportunity
  50. Advantages of deformation indices over systolic velocities in assessment of longitudinal systolic function in patients with heart failure and normal ejection fraction
  51. Lipid profile and plasma antioxidant status in sweet carbonated beverage-induced metabolic syndrome in rat
  52. Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy
  53. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?
  54. Electrocardiographic abnormalities of left ventricular repolarization: Prognostic implications in hypertensive post-menopausal women
  55. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be used together?
  56. Nutraceuticals in Cardiovascular Prevention: Lessons from Studies on Endothelial Function
  57. Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial
  58. Cardiac Magnetic Resonance With Edema Imaging Identifies Myocardium at Risk and Predicts Worse Outcome in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
  59. Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk
  60. IMPACT OF PRIOR CHRONIC ANTIPLATELET THERAPY ON SHORT- AND LONG-TERM ADVERSE EVENTS IN PATIENTS PRESENTING WITH AN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE ACUITY TRIAL
  61. Angiotensin receptor blockers in hypertension. New insights from Japan
  62. Hypertension in adolescents
  63. Systematic Strategy of Prophylactic Coronary Angiography Improves Long-Term Outcome After Major Vascular Surgery in Medium- to High-Risk Patients
  64. Noninvasive stress testing of myocardial perfusion defects: head-to-head comparison of thallium-201 SPECT to MRI perfusion
  65. Arterial Access-Site–Related Outcomes of Patients Undergoing Invasive Coronary Procedures for Acute Coronary Syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non–ST-ElevatiOn Acute Coronary Syndromes [PRESTO-...
  66. Heparin/PF4 antibodies formation after heparin treatment: Temporal aspects and long-term follow-up
  67. Myocardial Revascularization by Left Ventricular Assisted Beating Heart Is Associated With Reduced Systemic Inflammatory Response
  68. Transcatheter closure of postinfarction ventricular septal defect using the Amplatzer atrial septal defect occluder
  69. Early aggressive vs. initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: The Italian Elderly ACS study
  70. Intravenous contrast echocardiography after myocardial infarction: relationship among residual myocardial perfusion, contractile reserve and long-term remodelling
  71. Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion
  72. AngioJet thrombectomy for the treatment of coronary artery aneurysm after failed thrombolysis in acute myocardial infarction
  73. Patients With Hibernating Myocardium Show Altered Left Ventricular Volumes and Shape, Which Revert After Revascularization
  74. Percutaneous left ventricular assist device, TandemHearttm, for high‐risk percutaneous coronary revascularization. A single centre experience
  75. Successful treatment by percutaneous stent deployment of severe retrograde dissection of the right coronary artery extending into the sinus of Valsalva and ascending aorta
  76. The Anti-Anginal Drug Trimetazidine Reduces Neutrophil-Mediated Cardiac Reperfusion Injury
  77. Ultrastructural evidence of increased tolerance of hibernating myocardium to cardioplegic ischemia-reperfusion injury
  78. Effects of acute myocardial ischemia on QT dispersion by Dipyridamole stress echocardiography
  79. Microcirculation in Hypertension
  80. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects
  81. Effects of acute myocardial ischemia on QT dispersion: evaluation by dipyridamole-stress echocardiography
  82. Clinical manifestations of myocardial stunning
  83. Oxygen Radical-mediated Reduction in Basal and Agonist-evoked NO Release in Isolated Rat Heart
  84. Detection of Hydroxyl Radicals by -Phenylalanine Hydroxylation: A Specific Assay for Hydroxyl Radical Generation in Biological Systems
  85. Role of Oxidants in the Signaling Pathway of Preconditioning
  86. Prognostic value of midwall shortening fraction and its relation with left ventricular mass in systemic hypertension
  87. Value of a simple echocardiographic linear predictor of left ventricular mass in systemic hypertension
  88. Adenovirus-Mediated Acidic Fibroblast Growth Factor Gene Transfer Induces Angiogenesis in the Nonischemic Rabbit Heart
  89. “Warm-Up” Phenomenon Detected by Electrocardiographic Ambulatory Monitoring in Adult and Older Patients
  90. Reperfusion injury: Experimental evidence and clinical implications
  91. Age-Related Decrease in Cardiac Tolerance to Oxidative Stress
  92. Role of Angiotensin II in Myocardial Ischemia/ Reperfusion Injury
  93. A Short Burst of Oxygen Radicals at Reflow Induces Sustained Release of Oxidized Glutathione from Postischemic Hearts
  94. Characterization of Platelet-activating Factor Acetylhydrolase in Human Bronchoalveolar Lavage
  95. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia
  96. ncreased low-density lipoprotein peroxidation in elderly men
  97. Role of Oxidative Metabolism on Endothelium-dependent Vascular Relaxation of Isolated Vessels
  98. Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals
  99. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion
  100. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia
  101. 917-97 Decreased Resistance Against Oxidation of LDL from Patients with Homozigous Familial Hypercholesterolemia
  102. 713-3 β-Blocker Agents Prevent Oxygen Radical-induced Human Apolipoprotein-B100 Oxidation
  103. The Functional Recovery of Post-Ischemic Myocardium Requires Glycolysis During Early Reperfusion
  104. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: Studies in a rabbit model of coronary artery occlusion-reperfusion
  105. The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts
  106. Calcium Antagonists and Experimental Myocardial Ischemia Reperfusion Injury
  107. Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical scavenger mannitol, on reperfusion injury in isolated rabbit hearts
  108. Role of oxygen free radicals in myocardial ischemia-reperfusion injury
  109. Role of glycolytic and oxidative metabolism in endothelium-dependent relaxation in isolated rabbit aorta
  110. Calcium Antagonists and Experimental Myocardial Ischemia Reperfusion Injury
  111. Calcium Antagonists and Experimental Myocardial Ischemia Reperfusion Injury
  112. Myocardial reperfusion injury: Mechanisms and management—a review
  113. Reduction in infarct size by the phospholipase inhibitor quinacrine in dogs with coronary artery occlusion
  114. Paradoxical effects of cardiac arrest by multidose potassium cardioplegia on myocardial lysosome integrity and phospholipid content
  115. Hydrogen peroxide modulates platelet aggregation in vitro
  116. Electrophysiological alterations caused by free radicals in isolated myocytes
  117. Does ischemia affect the ability of the heart to release oxidized glutathione?
  118. Effects of Pharmacological Treatment of Acute Myocardial Infarction on Left Ventricular Function
  119. Effects of Pharmacological Treatment of Acute Myocardial Infarction on Left Ventricular Function
  120. Can free radicals explain reperfusion damage?
  121. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion
  122. Evidence That Free Radicals Result in Reperfusion Injury in Heart Muscle
  123. Myocardial consequences of reperfusion
  124. Assessment of myocardial blood flow by real-time infrared imaging
  125. Effect of repeated episodes of drug-induced ventricular dyskinesia on subsequent regional function in the dog: Comparison with myocardial stunning produced by repeated coronary occlusions
  126. Mepindolol Reduces Myocardial Necrosis in Rats with Coronary Artery Occlusion
  127. Dilazep-induced reduction of ischemic necrosis in rats with coronary artery occlusion
  128. The effects of iodination on the polypeptide heterogeneity of thyroglobulin
  129. Further Observations on the Electrophysiologic Effects of Oral Amiodarone Therapy
  130. A nonincinerative rate-sensing method for the determination of iodine in iodoproteins
  131. The use of 1-anilino naphthalene-8-sulfonate (ANS) for studying the effects of iodination on thyroglobulin conformation
  132. Polypeptide chain composition of thyroglobulin